Ignite Creation Date:
2024-05-06 @ 1:20 AM
Last Modification Date:
2024-10-26 @ 11:02 AM
Study NCT ID:
NCT01785810
Status:
COMPLETED
Last Update Posted:
2021-01-11
First Post:
2013-02-05
Brief Title:
Phase II Maraviroc for GVHD Prevention
Sponsor:
Abramson Cancer Center at Penn Medicine
Organization:
Abramson Cancer Center at Penn Medicine
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Hematologic Malignancy |
Keywords: